AVADEL PHARMACEUTICALS - COM (AVDL)

Historical Holders from Q4 2016 to Q3 2025

Symbol
AVDL on Nasdaq
Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
737,501
Holdings value
$11,261,641
Number of holders
3
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 737,501 $11,261,641 $15.27 3
2025 Q2 737,501 $6,526,891 $8.85 3
2025 Q1 737,501 $5,774,641 +$3,915 $7.83 3
2024 Q4 737,001 $7,745,886 -$4,367,115 $10.51 3
2024 Q3 1,070,001 $14,032,886 -$83,726,145 $13.12 5
2024 Q2 7,025,014 $98,771,327 -$1,024,949,936 $14.06 10
2024 Q1 67,722,532 $1,143,898,167 +$203,068,084 $16.89 118
2023 Q4 56,101,941 $792,157,961 +$22,530,113 $14.12 111
2023 Q3 54,278,206 $559,092,743 +$10,494,218 $10.3 97
2023 Q2 51,954,100 $856,215,990 +$74,681,603 $16.48 100
2023 Q1 48,372,275 $443,043,185 +$137,759,207 $9.16 89
2022 Q4 33,455,552 $239,492,674 +$16,050,496 $7.16 83
2022 Q3 31,382,476 $157,240,505 -$10,626,389 $5.01 73
2022 Q2 33,736,494 $82,314,348 -$28,513,599 $2.44 76
2022 Q1 35,805,994 $244,546,225 -$688,773 $6.83 78
2021 Q4 34,932,136 $282,263,295 +$4,296,837 $8.08 80
2021 Q3 32,066,701 $314,225,653 -$2,362,887 $9.8 81
2021 Q2 32,560,006 $219,142,519 -$1,408,221 $6.73 78
2021 Q1 32,624,275 $294,399,454 +$1,571,028 $9.04 77
2020 Q4 32,022,142 $213,943,727 +$3,675,725 $6.68 79
2020 Q3 31,489,522 $158,737,955 -$40,676,485 $5.04 77
2020 Q2 36,267,175 $293,031,072 +$73,438,051 $8.08 73
2020 Q1 26,858,841 $211,297,159 +$55,745,053 $7.94 55
2019 Q4 18,381,676 $138,778,000 +$3,405,718 $7.55 42
2019 Q3 19,369,854 $80,579,000 +$264,036 $4.16 40
2019 Q2 19,348,881 $55,916,464 -$532,703 $2.89 41
2019 Q1 19,605,364 $28,234,677 -$885,274 $1.44 39
2018 Q4 19,797,043 $51,037,773 -$3,326,792 $2.58 49
2018 Q3 20,161,887 $88,500,210 -$2,841,826 $4.39 63
2018 Q2 20,601,522 $126,287,755 -$36,188,917 $6.13 67
2018 Q1 25,894,045 $188,761,103 -$4,895,064 $7.29 72
2017 Q4 26,385,773 $216,351,759 -$17,017,220 $8.2 76
2017 Q3 27,182,084 $284,631,551 -$5,504,957 $10.5 79
2017 Q2 27,736,858 $305,936,220 +$24,728,608 $11.03 76
2017 Q1 27,900,060 $270,237,807 +$228,176,242 $9.68 70
2016 Q4 4,300,449 $44,678,000 +$44,678,000 $10.39 6